Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Dallas TX, Houston TX, Nashville TN, Rochester MN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07491445

Phase3, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Denver CO, Nashville TN, Atlanta GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase1, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Southlake TX, Garland TX, Cedar Park TX, San Antonio TX,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

IEEM- Work:Rest Cycles in Burn Survivors- Humidity

for
Hyperthermia, Burn Injury
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT06966336

Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Dallas TX, Austin TX, Houston TX, Laredo TX, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Plano TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase2, Phase3, Recruiting

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Stingray Therapeutics

Sex: All

Age: 18+

Code: NCT06589440

Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Dallas TX, Houston TX, Little Rock AR, Nashville TN,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Colorectal Cancer,
Location: Dallas TX, Tyler TX, Oklahoma City OK, Houston TX,
Sponsor: Merus B.V.

Sex: All

Age: 18+

Code: NCT03526835

Phase1, Phase2, Recruiting

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

for
Limited Stage Small Cell Lung Cancer
Location: Dallas TX, Denison TX, Austin TX, San Antonio TX,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT06773910

Phase2, Recruiting

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
Location: Dallas TX, Houston TX, Aurora CO, Nashville TN,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07223203

Phase3, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Houston TX, Denver CO, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase1, Recruiting
Featured

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

for
Hepatocellular Carcinoma
Location: Dallas TX, Abilene TX, St Louis MO, Louisville KY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06109272

Phase2, Phase3, Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Dallas TX, San Antonio TX, Nashville TN, Salem VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Dallas TX, Allen TX, Abilene TX, New Braunfels TX,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Sickle Cell Kidney Biorepository

for
Sickle Cell Trait, Sickle Cell Disease (SCD),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT07064174

Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Lincoln NE, Nashville TN, Atlanta GA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase2, Recruiting

KRT-232 and TKI Study in Chronic Myeloid Leukemia

for
Chronic Myeloid Leukemia
Location: Dallas TX, Birmingham AL, Milwaukee WI, Augusta GA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04835584

Phase1, Phase2, Recruiting

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: Dallas TX, Laredo TX, Appleton WI, Toledo OH,
Sponsor: NGM Biopharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07033026

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Dallas TX, Pearland TX, Amarillo TX, Germantown TN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase1, Phase2, Recruiting